Literature DB >> 2536781

Prevalence of genital papillomavirus infection among women attending a college student health clinic or a sexually transmitted disease clinic.

N B Kiviat1, L A Koutsky, J A Paavonen, D A Galloway, C W Critchlow, A M Beckmann, J K McDougall, M L Peterson, C E Stevens, C M Lipinski.   

Abstract

We examined 454 women randomly selected from a Sexually Transmitted Disease (STD) Clinic and 545 consecutive college women undergoing annual examination. Patients were examined for visible genital warts, koilocytes, and human papillomavirus (HPV) antigen on cervical smears and for cervical HPV DNA types 6, 11, 16, 18, and 31. Genital warts were found in 11% of STD Clinic patients and 2% of students (P less than .001). Among those women without genital warts, HPV DNA or antigen was detected in cervical specimens from 10.6% of STD Clinic patients and 11.4% of students (P = .73), with HPV type 16, 18, or 31 being 9.8 times more frequent than cervical HPV 6 or 11 among students and 5.8 times more frequent among STD Clinic patients. Dysplasia was present in 53% of those with HPV type 6 or 11 and in 41% of those with HPV type 16, 18, or 31 DNA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536781     DOI: 10.1093/infdis/159.2.293

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

1.  Sexual risk behavior in women with cervical human papillomavirus infection.

Authors:  B Sikström; D Hellberg; S Nilsson; C Brihmer; P A Mårdh
Journal:  Arch Sex Behav       Date:  1996-08

Review 2.  The role of vaccines in the control of STDs: HPV vaccines.

Authors:  I H Frazer
Journal:  Genitourin Med       Date:  1996-12

3.  Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree.

Authors:  L Ho; S Y Chan; V Chow; T Chong; S K Tay; L L Villa; H U Bernard
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

4.  Seropositivity against HPV 16 capsids: a better marker of past sexual behaviour than presence of HPV DNA.

Authors:  A O Olsen; J Dillner; K Gjøen; P Magnus
Journal:  Genitourin Med       Date:  1997-04

5.  Oestrogen receptor transcripts associated with cervical human papillomavirus infection.

Authors:  M L Shew; R McGlennen; N Zaidi; M Westerheim; M Ireland; S Anderson
Journal:  Sex Transm Infect       Date:  2002-06       Impact factor: 3.519

6.  Cervical papillomavirus infection and cervical dysplasia in Hispanic, Native American, and non-Hispanic white women in New Mexico.

Authors:  T M Becker; C M Wheeler; N S McGough; S W Jordan; M Dorin; J Miller
Journal:  Am J Public Health       Date:  1991-05       Impact factor: 9.308

7.  Prevalence of genital human papillomavirus infections in patients at a sexually transmitted diseases clinic.

Authors:  Y L Chang; C Y Lin; C J Tseng; H S Cheng; H C Lin; C C Pao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-05       Impact factor: 3.267

8.  Oral contraceptive use and human papillomavirus infection in women without abnormal cytological results.

Authors:  G Veress; T Csiky-Mészáros; J Czeglédy; L Gergely
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

Review 9.  Pathogenesis of genital HPV infection.

Authors:  A Schneider
Journal:  Genitourin Med       Date:  1993-06

Review 10.  Pathobiology of papillomavirus-related cervical diseases: prospects for immunodiagnosis.

Authors:  C P Crum; S Barber; J K Roche
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.